Identifizierung und Charakterisierung exogener und endogener endothelialer Faktoren für die Ätiopathogenese der Atherosklerose Markus Tölle1121314252Anhang 1: LebenslaufAnhang 2: Publikationsverzeichnis, Abstrakts, Vorträge, Förderungen Anhang 3: Abbildungen379#303378#227378#303623#213378#302453#176378#302378#302377#302378#303377#303377#302378#302378#302378#302377#302377#302378#303378#303378#302377#302378#302378#303378#302378#302378#302378#302378#302378#302Anhang 4: LiteraturverzeichnisdeInhaltsverzeichnisHilfe Anhang 4: Literaturverzeichnis [1] Bombeli, T.; Mueller, M. und Haeberli, A. (1997): Anticoagulant properties of the vascular endothelium, Thromb Haemost, (Band 77), No. 3, Seite 408-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9065986 [2] Griendling, K. K. und Alexander, R. W. (1997): Oxidative stress and cardiovascular disease, Circulation, (Band 96), No. 10, Seite 3264-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9396412 [3] Gimbrone, M. A., Jr. (1995): Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis, Am J Cardiol, (Band 75), No. 6, Seite 67B-70B. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7532351 [4] Grodos, D. und Tonglet, R. (1994): Scandinavian simvastatin study (4S), Lancet, (Band 344), No. 8939-8940, Seite 1768. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7997017 [5] McMurray, J. und Slattery, J. (1994): Scandinavian simvastatin study (4S), Lancet, (Band 344), No. 8939-8940, Seite 1765-6; author reply 1767-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7997012 [6] Gallis, B.; Corthals, G. L.; Goodlett, D. R.; Ueba, H.; Kim, F.; Presnell, S. R.; Figeys, D.; Harrison, D. G.; Berk, B. C.; Aebersold, R. und Corson, M. A. (1999): Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002, J Biol Chem, (Band 274), No. 42, Seite 30101-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10514497 [7] Glomset, J. A. (1968): The plasma lecithins:cholesterol acyltransferase reaction, J Lipid Res, (Band 9), No. 2, Seite 155-67. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=4868699 [8] Yuhanna, I. S.; Zhu, Y.; Cox, B. E.; Hahner, L. D.; Osborne-Lawrence, S.; Lu, P.; Marcel, Y. L.; Anderson, R. G.; Mendelsohn, M. E.; Hobbs, H. H. und Shaul, P. W. (2001): High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase, Nat Med, (Band 7), No. 7, Seite 853-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11433352 [9] Gong, M.; Wilson, M.; Kelly, T.; Su, W.; Dressman, J.; Kincer, J.; Matveev, S. V.; Guo, L.; Guerin, T.; Li, X. A.; Zhu, W.; Uittenbogaard, A. und Smart, E. J. (2003): HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner, J Clin Invest, (Band 111), No. 10, Seite 1579-87. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12750408 [10] Goetzl, E. J. und An, S. (1998): Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate, Faseb J, (Band 12), No. 15, Seite 1589-98. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9837849 [11] Spiegel, S. und Merrill, A. H., Jr. (1996): Sphingolipid metabolism and cell growth regulation, Faseb J, (Band 10), No. 12, Seite 1388-97. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8903509 [12] Hla, T.; Lee, M. J.; Ancellin, N.; Paik, J. H. und Kluk, M. J. (2001): Lysophospholipids--receptor revelations, Science, (Band 294), No. 5548, Seite 1875-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11729304 [13] Chun, J.; Goetzl, E. J.; Hla, T.; Igarashi, Y.; Lynch, K. R.; Moolenaar, W.; Pyne, S. und Tigyi, G. (2002): International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature, Pharmacol Rev, (Band 54), No. 2, Seite 265-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12037142 [14] Mandala, S.; Hajdu, R.; Bergstrom, J.; Quackenbush, E.; Xie, J.; Milligan, J.; Thornton, R.; Shei, G. J.; Card, D.; Keohane, C.; Rosenbach, M.; Hale, J.; Lynch, C. L.; Rupprecht, K.; Parsons, W. und Rosen, H. (2002): Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists, Science, (Band 296), No. 5566, Seite 346-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11923495 [15] Matloubian, M.; Lo, C. G.; Cinamon, G.; Lesneski, M. J.; Xu, Y.; Brinkmann, V.; Allende, M. L.; Proia, R. L. und Cyster, J. G. (2004): Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1, Nature, (Band 427), No. 6972, Seite 355-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14737169 [16] Brinkmann, V.; Pinschewer, D.; Chiba, K. und Feng, L. (2000): FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation, Trends Pharmacol Sci, (Band 21), No. 2, Seite 49-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10664606 [17] Vitko, S. und Viklicky, O. (2004): Cyclosporine renal dysfunction, Transplant Proc, (Band 36), No. 2 Suppl, Seite 243S-247S. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15041346 [18] El-Hamamsy, I.; Grant, M.; Stevens, L. M.; Malo, O.; Carrier, M. und Perrault, L. P. (2005): Cyclosporine-induced coronary endothelial dysfunction: is tetrahydrobiopterin the solution?, Transplant Proc, (Band 37), No. 5, Seite 2365-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15964417 [19] Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y.; Yazaki, Y.; Goto, K. und Masaki, T. (1988): A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, (Band 332), No. 6163, Seite 411-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2451132 [20] Miller, V. M. und Vanhoutte, P. M. (1985): Endothelium-dependent contractions to arachidonic acid are mediated by products of cyclooxygenase, Am J Physiol, (Band 248), No. 4 Pt 2, Seite H432-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3920919 [21] Cosentino, F.; Hishikawa, K.; Katusic, Z. S. und Luscher, T. F. (1997): High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells, Circulation, (Band 96), No. 1, Seite 25-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9236411 [22] Kaiser, R. A.; Oxhorn, B. C.; Andrews, G. und Buxton, I. L. (2002): Functional compartmentation of endothelial P2Y receptor signaling, Circ Res, (Band 91), No. 4, Seite 292-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12193461 [23] Johnsen, S. H.; Mathiesen, E. B.; Fosse, E.; Joakimsen, O.; Stensland-Bugge, E.; Njolstad, I. und Arnesen, E. (2005): Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromso study, Circulation, (Band 112), No. 4, Seite 498-504. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16027250 [24] Schulte, H.; Cullen, P. und Assmann, G. (1999): Obesity, mortality and cardiovascular disease in the Munster Heart Study (PROCAM), Atherosclerosis, (Band 144), No. 1, Seite 199-209. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10381293 [25] O'Connell, B. J. und Genest, J., Jr. (2001): High-density lipoproteins and endothelial function, Circulation, (Band 104), No. 16, Seite 1978-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11602504 [26] Spieker, L. E.; Sudano, I.; Hurlimann, D.; Lerch, P. G.; Lang, M. G.; Binggeli, C.; Corti, R.; Ruschitzka, F.; Luscher, T. F. und Noll, G. (2002): High-density lipoprotein restores endothelial function in hypercholesterolemic men, Circulation, (Band 105), No. 12, Seite 1399-402. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11914243 [27] Fleisher, L. N.; Tall, A. R.; Witte, L. D.; Miller, R. W. und Cannon, P. J. (1982): Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins, J Biol Chem, (Band 257), No. 12, Seite 6653-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7045092 [28] Dimmeler, S. und Zeiher, A. M. (1999): Nitric oxide-an endothelial cell survival factor, Cell Death Differ, (Band 6), No. 10, Seite 964-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10556973 [29] Dimmeler, S.; Fleming, I.; Fisslthaler, B.; Hermann, C.; Busse, R. und Zeiher, A. M. (1999): Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, (Band 399), No. 6736, Seite 601-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10376603 [30] Boo, Y. C.; Sorescu, G.; Boyd, N.; Shiojima, I.; Walsh, K.; Du, J. und Jo, H. (2002): Shear stress stimulates phosphorylation of endothelial nitric-oxide synthase at Ser1179 by Akt-independent mechanisms: role of protein kinase A, J Biol Chem, (Band 277), No. 5, Seite 3388-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11729190 [31] Haynes, M. P.; Sinha, D.; Russell, K. S.; Collinge, M.; Fulton, D.; Morales-Ruiz, M.; Sessa, W. C. und Bender, J. R. (2000): Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells, Circ Res, (Band 87), No. 8, Seite 677-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11029403 [32] Zachary, I. und Gliki, G. (2001): Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family, Cardiovasc Res, (Band 49), No. 3, Seite 568-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11166270 [33] Nofer, J. R.; Levkau, B.; Wolinska, I.; Junker, R.; Fobker, M.; von Eckardstein, A.; Seedorf, U. und Assmann, G. (2001): Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids, J Biol Chem, (Band 276), No. 37, Seite 34480-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11432865 [34] Mineo, C.; Yuhanna, I. S.; Quon, M. J. und Shaul, P. W. (2003): High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases, J Biol Chem, (Band 278), No. 11, Seite 9142-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12511559 [35] Dantas, A. P.; Igarashi, J. und Michel, T. (2003): Sphingosine 1-phosphate and control of vascular tone, Am J Physiol Heart Circ Physiol, (Band 284), No. 6, Seite H2045-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12742827 [36] Finigan, J. H.; Dudek, S. M.; Singleton, P. A.; Chiang, E. T.; Jacobson, J. R.; Camp, S. M.; Ye, S. Q. und Garcia, J. G. (2005): Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation, J Biol Chem, (Band 280), No. 17, Seite 17286-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15710622 [37] Nofer, J. R.; van der Giet, M.; Tolle, M.; Wolinska, I.; von Wnuck Lipinski, K.; Baba, H. A.; Tietge, U. J.; Godecke, A.; Ishii, I.; Kleuser, B.; Schafers, M.; Fobker, M.; Zidek, W.; Assmann, G.; Chun, J. und Levkau, B. (2004): HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3, J Clin Invest, (Band 113), No. 4, Seite 569-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14966566 [38] Fukushima, N.; Ishii, I.; Contos, J. J.; Weiner, J. A. und Chun, J. (2001): Lysophospholipid receptors, Annu Rev Pharmacol Toxicol, (Band 41), Seite 507-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11264467 [39] Levade, T.; Auge, N.; Veldman, R. J.; Cuvillier, O.; Negre-Salvayre, A. und Salvayre, R. (2001): Sphingolipid mediators in cardiovascular cell biology and pathology, Circ Res, (Band 89), No. 11, Seite 957-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11717151 [40] Yang, A. H.; Ishii, I. und Chun, J. (2002): In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice, Biochim Biophys Acta, (Band 1582), No. 1-3, Seite 197-203. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12069829 [41] Morales-Ruiz, M.; Lee, M. J.; Zollner, S.; Gratton, J. P.; Scotland, R.; Shiojima, I.; Walsh, K.; Hla, T. und Sessa, W. C. (2001): Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells, J Biol Chem, (Band 276), No. 22, Seite 19672-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11278592 [42] Lee, M. J.; Thangada, S.; Claffey, K. P.; Ancellin, N.; Liu, C. H.; Kluk, M.; Volpi, M.; Sha'afi, R. I. und Hla, T. (1999): Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate, Cell, (Band 99), No. 3, Seite 301-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10555146 [43] McGiffert, C.; Contos, J. J.; Friedman, B. und Chun, J. (2002): Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p(1) in neurogenesis and s1p(1-3) in angiogenesis, FEBS Lett, (Band 531), No. 1, Seite 103-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12401212 [44] Zhang, G.; Contos, J. J.; Weiner, J. A.; Fukushima, N. und Chun, J. (1999): Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate, Gene, (Band 227), No. 1, Seite 89-99. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9931453 [45] Ishii, I.; Fukushima, N.; Ye, X. und Chun, J. (2004): Lysophospholipid receptors: signaling and biology, Annu Rev Biochem, (Band 73), Seite 321-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15189145 [46] Ohmori, T.; Yatomi, Y.; Osada, M.; Kazama, F.; Takafuta, T.; Ikeda, H. und Ozaki, Y. (2003): Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2, Cardiovasc Res, (Band 58), No. 1, Seite 170-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12667959 [47] Brinkmann, V. und Lynch, K. R. (2002): FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity, Curr Opin Immunol, (Band 14), No. 5, Seite 569-75. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12183155 [48] Aki, F. T. und Kahan, B. D. (2003): FTY720: A new kid on the block for transplant immunosuppression, Expert Opin Biol Ther, (Band 3), No. 4, Seite 665-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12831371 [49] Paugh, S. W.; Payne, S. G.; Barbour, S. E.; Milstien, S. und Spiegel, S. (2003): The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2, FEBS Lett, (Band 554), No. 1-2, Seite 189-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14596938 [50] Kharel, Y.; Lee, S.; Snyder, A. H.; Sheasley-O'neill S, L.; Morris, M. A.; Setiady, Y.; Zhu, R.; Zigler, M. A.; Burcin, T. L.; Ley, K.; Tung, K. S.; Engelhard, V. H.; Macdonald, T. L. und Lynch, K. R. (2005): Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720, J Biol Chem. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16093248 [51] Busauschina, A.; Schnuelle, P. und van der Woude, F. J. (2004): Cyclosporine nephrotoxicity, Transplant Proc, (Band 36), No. 2 Suppl, Seite 229S-233S. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15041343 [52] Hwang, M. W.; Matsumori, A.; Furukawa, Y.; Ono, K.; Okada, M.; Iwasaki, A.; Hara, M. und Sasayama, S. (1999): FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation, Circulation, (Band 100), No. 12, Seite 1322-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10491378 [53] Motte, S.; Communi, D.; Pirotton, S. und Boeynaems, J. M. (1995): Involvement of multiple receptors in the actions of extracellular ATP: the example of vascular endothelial cells, Int J Biochem Cell Biol, (Band 27), No. 1, Seite 1-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7757878 [54] Inscho, E. W.; Cook, A. K.; Mui, V. und Miller, J. (1998): Direct assessment of renal microvascular responses to P2-purinoceptor agonists, Am J Physiol, (Band 274), No. 4 Pt 2, Seite F718-27. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9575896 [55] Cameselle, J. C.; Costas, M. J.; Sillero, M. A. und Sillero, A. (1982): Bis-(5'-guanosyl) tetraphosphatase in rat tissues, Biochem J, (Band 201), No. 2, Seite 405-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6282267